FIRST RESULTS OF INTRAVENOUS APPLICATION OF BISPECIFIC ANTIBODY (CD3/CD19 SHR-1) TO PATIENTS WITH CD19 POSITIVE B-CELL MALIGNANCIES - A PHASE-1 STUDY

被引：0
|
作者：
VANHOUTEN, AA
HAAGEN, IA
CLARK, M
GEERARS, A
DELAU, W
BAST, EJEG
DEGAST, GC
机构：
[1] UNIV HOSP UTRECHT,DEPT HEMATOL,UTRECHT,NETHERLANDS
[2] UNIV HOSP UTRECHT,DEPT IMMUNOL,UTRECHT,NETHERLANDS
[3] UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE,CAMBS,ENGLAND
来源：
EXPERIMENTAL HEMATOLOGY | 1993年 / 21卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1120 / 1120
页数：1
相关论文
共 50 条
  • [21] CD3/CD19 depleted grafts for haploidentical transplantation in children:: results of a pilot study
    Lang, P
    Schumm, M
    Pfeiffer, M
    Müller, I
    Greil, J
    Bader, P
    Klingebiel, T
    Handgretinger, R
    BONE MARROW TRANSPLANTATION, 2006, 37 : S33 - S34
  • [22] CD47/SIRPα blocking enhances CD19/CD3-bispecific T cell engager antibody-mediated lysis of B cell malignancies
    Xu, Lijun
    Wang, Shanlong
    Li, Jie
    Li, Bingyu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 509 (03) : 739 - 745
  • [23] CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression
    Meetze, Kristan
    Mehta, Naveen K.
    Li, Bochong
    Michaelson, Jennifer S.
    Baeuerle, Patrick A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [24] Enhanced efficacy of CD19/CD22 bispecific CAR-T cells with EAAAK linker on B-cell malignancies
    Ma, Renyuxue
    You, Fengtao
    Tian, Shuaiyu
    Zhang, Tingting
    Tian, Xiaopeng
    Xiang, Shufen
    Wu, Hai
    Yang, Nan
    An, Gangli
    Yang, Lin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (01) : 64 - 74
  • [25] AFM11, a CD19/CD3 bispecific tandab, to facilitate T-cell-mediated killing of CD19+cells.
    Zhukovsky, Eugene
    Reusch, Uwe
    Burkhardt, Carmen
    Knackmuss, Stefan
    Fucek, Ivica
    Eser, Markus
    McAleese, Fionnuala
    Ellwanger, Kristina
    Little, Melvyn
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] TNB-486, a Novel Fully Human Bispecific CD19 x CD3 Antibody That Kills CD19-Positive Tumor Cells with Minimal Cytokine Secretion
    Malik, Harbani
    Buelow, Ben
    Rangaswamy, Udaya
    Balasubramani, Aarti
    Boudreau, Andrew
    Dang, Kevin
    Davison, Laura
    Aldred, Shelley Force
    Harris, Katherine Marie
    Iyer, Suhasini
    Jorgensen, Brett
    Pham, Duy
    Prabhakar, Kirthana
    Schellenberger, Ute
    Ugamraj, Harshad
    Trinklein, Nathan
    Van Schooten, Wim
    BLOOD, 2019, 134
  • [27] Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies
    Bachanova, Veronika
    Frankel, Arthur E.
    Cao, Qing
    Lewis, Dixie
    Grzywacz, Bartosz
    Verneris, Michael R.
    Ustun, Celalettin
    Lazaryan, Aleksandr
    McClune, Brian
    Warlick, Erica D.
    Kantarjian, Hagop
    Weisdorf, Daniel J.
    Miller, Jeffrey S.
    Vallera, Daniel A.
    CLINICAL CANCER RESEARCH, 2015, 21 (06) : 1267 - 1272
  • [28] A Novel Fully Human Bispecific CD19 x CD3 Antibody That Kills Lymphoma Cells with Minimal Cytokine Secretion
    Malik, Harbani
    Buelow, Ben
    Avanzino, Brian
    Balasubramani, Aarti
    Boudreau, Andrew
    Clarke, Starlynn
    Dang, Kevin
    Davison, Laura
    Aldred, Shelley Force
    Harris, Katherine
    Jorgensen, Brett
    Li, Yuping
    Medlari, Harish
    Narayan, Keshav
    Ogana, Heather
    Duy Pham
    Prabhakar, Kirthana
    Rangaswamy, Udaya
    Sankaran, Preethi
    Schellenberger, Ute
    Ugamraj, Harshad
    Trinklein, Nathan
    Van Schooten, Wim
    BLOOD, 2018, 132
  • [29] Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia
    Buatois, Vanessa
    Johnson, Zoe
    Salgado-Pires, Susana
    Papaioannou, Anne
    Hatterer, Eric
    Chauchet, Xavier
    Richard, Francoise
    Barba, Leticia
    Daubeuf, Bruno
    Cons, Laura
    Broyer, Lucile
    D'Asaro, Matilde
    Matthes, Thomas
    LeGallou, Simon
    Fest, Thierry
    Tarte, Karin
    Hinojosa, Robert K. Clarke
    Ferrer, Eulalia Genesca
    Ribera, Jose Maria
    Dey, Aditi
    Bailey, Katharine
    Fielding, Adele K.
    Eissenberg, Linda
    Ritchey, Julie
    Rettig, Michael
    DiPersio, John F.
    Kosco-Vilbois, Marie H.
    Masternak, Krzysztof
    Fischer, Nicolas
    Shang, Limin
    Ferlin, Walter G.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (08) : 1739 - 1751
  • [30] Blinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy
    Goebeler, Maria-Elisabeth
    Bargou, Ralf
    LEUKEMIA & LYMPHOMA, 2016, 57 (05) : 1021 - 1032
12345